Jessica Migliavacca

Jessica Migliavacca

Auto-generated profile, based on publicly available information

Jessica Migliavacca

Pediatric Molecular Neuro-Oncology Lab, Children’s Research Center, University Children’s Hospital Zürich, Zürich, Switzerland

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2020 in Neoplasia
Verified
Journal Article
Open access
MSMarc Thomas Schönholzer
Marc Thomas Schönholzer
JMJessica Migliavacca
Jessica Migliavacca
EAElena Alvarez
Elena Alvarez
KKKarthiga Santhana Kumar
Karthiga Santhana Kumar
ANAnuja Neve
Anuja Neve
MBMartin Baumgartner
Martin Baumgartner
• Growth factor signaling causes sustained nuclear ERK1/2 activation. • The SCR and BCR/ABL inhibitor dasatinib blocks ERK1/2 and represses cell invasion. • EGF-stimulated cells may escape dasatinib inhibition of invasion through mesenchymal to amoeboid transition. • Combined inhibition of SRC and Rho-kinase signaling is necessary to completely block EGF-induced invasion.

16 March 2022 in Life Science Alliance
Verified
Journal Article
Open access
PDF file
CCCharles Capdeville
Charles Capdeville
LRLinda Russo
Linda Russo
DPDavid Penton
David Penton
JMJessica Migliavacca
Jessica Migliavacca
MZMilica Zecevic
Milica Zecevic
MBMartin Baumgartner
Martin Baumgartner
The composition of the plasma membrane (PM)-associated proteome of tumor cells determines cell–cell and cell–matrix interactions and the response to environmental cues. Whether the PM-associated proteome impacts the phenotype of Medulloblastoma (MB) tumor cells and how it adapts in response to growth factor cues is poorly understood. Using a spatial proteomics approach, we observed that hepatocyte growth factor (HGF)-induced activation of the receptor tyrosine kinase c-MET in MB cells changes the abundance of transmembrane and membrane-associated proteins. The depletion of MAP4K4, a pro-migratory effector kinase downstream of c-MET, leads to a specific decrease of the adhesion and immunomodulatory receptor CD155 and of components of the fast-endophilin–mediated endocytosis (FEME) machinery in the PM-associated proteome of HGF-activated MB cells. The decreased surface expression of CD155 or of the fast-endophilin–mediated endocytosis effector endophilin-A1 reduces growth and invasiveness of MB tumor cells in the tissue context. These data thus describe a novel function of MAP4K4 in the control of the PM-associated proteome of tumor cells and identified two downstream effector mechanisms controlling proliferation and invasiveness of MB cells.

1 September 2013 in Advanced Materials Research
Verified
Journal Article
Closed access
PDF file
FAFRANCESCO AUGELLI
FRANCESCO AUGELLI
ABArianna Bordina
Arianna Bordina
JMJessica Migliavacca
Jessica Migliavacca
The Ducal Palace in Sabbioneta, commissioned by Vespasiano Gonzaga in the end of 16th century, keeps four precious wooden ceilings inside. Rough wooden planks nailed to a skeleton structure creates the support for fine wood decorative elements. The requirement of a conservation work has prompted a diagnosis phase about the ceilings as a whole. This was carried out by closed up observations, drilling tests and laboratory analysis.

8 May 2021 in bioRxiv
Verified
Preprint
Open access
PDF file
JMJessica Migliavacca
Jessica Migliavacca
BZBuket Züllig
Buket Züllig
CCCharles Capdeville
Charles Capdeville
MGMichael Grotzer
Michael Grotzer
MBMartin Baumgartner
Martin Baumgartner
MAP4K4 has been correlated with increased cell motility and reduced proliferation in mammalian cells. Consequences and regulation of this dichotomous functionality of MAP4K4 in tumor cells remained elusive. We find that MAP4K4 interacts with the STRN3 protein in medulloblastoma and that STRN3 and MAP4K4 exert opposing functions in Hippo tumor suppressor signaling and clonal growth. However, depletion of either STRN3 or MAP4K4 reduces migration and tissue invasion, and concomitant loss of both proteins halts tumor cell growth in the cerebellar tissue. Mechanistically, STRN3 couples MAP4K4 to the protein phosphatase 2A, which inactivates growth repressing activities of MAP4K4. In parallel, STRN3 enables growth factor-induced PKCθ activation and the direct phosphorylation of VASP S157 by MAP4K4, which are necessary for efficient migration and tissue invasion. Thus, STRN3 controls MAP4K4 functionality in growth factor-activated tumor cells, and the cooperation of the two proteins promotes invasiveness through nPKCs and VASP and increases proliferation via inactivation of Hippo signaling. Targeting of the STRN3-MAP4K4 cooperation could reactivate Hippo signaling and repress invasiveness in growth factor-driven tumors. Graphical